How to Navigate Ecosystem Connect NEWDistinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats
68Ga-AAZTA-NI-093 PET/CT: First-in-human Study in Patients With Prostate Cancer
Description:
68Ga-AAZTA-093 is a novel radiotracer incorporating a hypoxia sensitive nitroimidazole(NI)-moiety and a PSMA-targeting. In this study, we observed the safety, biodistribution, radiation dosimetry and diagnostic value of 68Ga-AAZTA-NI-093 PET/CT in patients with prostate cancer.
Sponsor:
First Affiliated Hospital of Fujian Medical University
Government Study Link:
NCT06612580 - Click here to see study onClinicalTrials.gov
68Ga-AAZTA-NI-093
Isotope(s):
Target(s):
- PSMA
